133 related articles for article (PubMed ID: 9285079)
1. Electrophysiological indices of information processing in methylphenidate responders.
Winsberg BG; Javitt DC; Silipo GS
Biol Psychiatry; 1997 Sep; 42(6):434-45. PubMed ID: 9285079
[TBL] [Abstract][Full Text] [Related]
2. Mismatch negativity in hyperactive children: effects of methylphenidate.
Winsberg BG; Javitt DC; Silipo GS; Doneshka P
Psychopharmacol Bull; 1993; 29(2):229-33. PubMed ID: 8290670
[TBL] [Abstract][Full Text] [Related]
3. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate.
Sangal RB; Sangal JM
Clin Neurophysiol; 2004 Jan; 115(1):188-93. PubMed ID: 14706487
[TBL] [Abstract][Full Text] [Related]
4. Effects of osmotic-release methylphenidate in attention-deficit/hyperactivity disorder as measured by event-related potentials.
Sawada M; Iida J; Ota T; Negoro H; Tanaka S; Sadamatsu M; Kishimoto T
Psychiatry Clin Neurosci; 2010 Oct; 64(5):491-8. PubMed ID: 20923428
[TBL] [Abstract][Full Text] [Related]
5. Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate.
Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Camfferman G; Buitelaar JK; Koelega HS
Psychophysiology; 2000 May; 37(3):334-46. PubMed ID: 10860411
[TBL] [Abstract][Full Text] [Related]
6. Spatial orienting and focused attention in attention deficit hyperactivity disorder.
Novak GP; Solanto M; Abikoff H
Psychophysiology; 1995 Nov; 32(6):546-59. PubMed ID: 8524989
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate selectively modulates one sub-component of the no-go P3 in pediatric ADHD medication responders.
Aasen IE; Øgrim G; Kropotov J; Brunner JF
Biol Psychol; 2018 Apr; 134():30-38. PubMed ID: 29476840
[TBL] [Abstract][Full Text] [Related]
8. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder.
Ozdag MF; Yorbik O; Ulas UH; Hamamcioglu K; Vural O
Int J Pediatr Otorhinolaryngol; 2004 Oct; 68(10):1267-72. PubMed ID: 15364497
[TBL] [Abstract][Full Text] [Related]
9. Event-related wave activity in the EEG provides new marker of ADHD.
Alexander DM; Hermens DF; Keage HA; Clark CR; Williams LM; Kohn MR; Clarke SD; Lamb C; Gordon E
Clin Neurophysiol; 2008 Jan; 119(1):163-79. PubMed ID: 18054279
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study.
Rubinson M; Horowitz I; Naim-Feil J; Gothelf D; Levit-Binnun N; Moses E
PLoS One; 2019; 14(5):e0217383. PubMed ID: 31150439
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate effects on EEG, behavior, and performance in boys with ADHD.
Swartwood MO; Swartwood JN; Lubar JF; Timmermann DL; Zimmerman AW; Muenchen RA
Pediatr Neurol; 1998 Mar; 18(3):244-50. PubMed ID: 9568922
[TBL] [Abstract][Full Text] [Related]
12. Differences in plasma concentrations of the D- and L-threo methylphenidate enantiomers in responding and non-responding children with attention-deficit hyperactivity disorder.
Jonkman LM; Verbaten MN; de Boer D; Maes RA; Buitelaar JK; Kemner C; van Engeland H; Koelega HS
Psychiatry Res; 1998 Mar; 78(1-2):115-8. PubMed ID: 9579707
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder.
Pliszka SR; Liotti M; Bailey BY; Perez R; Glahn D; Semrud-Clikeman M
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):356-66. PubMed ID: 17630869
[TBL] [Abstract][Full Text] [Related]
14. Effects of motivation and medication on electrophysiological markers of response inhibition in children with attention-deficit/hyperactivity disorder.
Groom MJ; Scerif G; Liddle PF; Batty MJ; Liddle EB; Roberts KL; Cahill JD; Liotti M; Hollis C
Biol Psychiatry; 2010 Apr; 67(7):624-31. PubMed ID: 19914599
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate improves deficient error evaluation in children with ADHD: an event-related brain potential study.
Jonkman LM; van Melis JJ; Kemner C; Markus CR
Biol Psychol; 2007 Oct; 76(3):217-29. PubMed ID: 17904268
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder.
Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
J Child Adolesc Psychopharmacol; 2016 May; 26(4):344-53. PubMed ID: 26771913
[TBL] [Abstract][Full Text] [Related]
17. Changes of the brain electrical fields during the continuous performance test in attention-deficit hyperactivity disorder-boys depending on methylphenidate medication.
Zillessen KE; Scheuerpflug P; Fallgatter AJ; Strik WK; Warnke A
Clin Neurophysiol; 2001 Jul; 112(7):1166-73. PubMed ID: 11516728
[TBL] [Abstract][Full Text] [Related]
18. Effects of methylphenidate in ADHD adults on target evaluation processing reflected by event-related potentials.
Ohlmeier MD; Prox V; Zhang Y; Zedler M; Ziegenbein M; Emrich HM; Dietrich DE
Neurosci Lett; 2007 Sep; 424(3):149-54. PubMed ID: 17723273
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD.
Seifert J; Scheuerpflug P; Zillessen KE; Fallgatter A; Warnke A
J Neural Transm (Vienna); 2003 Jul; 110(7):821-9. PubMed ID: 12811642
[TBL] [Abstract][Full Text] [Related]
20. Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
Sangal RB; Sangal JM
Clin Neurophysiol; 2006 Sep; 117(9):1996-2006. PubMed ID: 16890481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
